Literature DB >> 18315551

Circulating anticoagulant glycosaminoglycans in mucopolysaccharidosis type I.

J Tolar, P J Orchard, N S Key, B R Blazar.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 18315551     DOI： 10.1111/j.1538-7836.2008.02936.x

Source DB:  PubMed          Journal:  J Thromb Haemost        ISSN： 1538-7836            Impact factor:   5.824


× No keyword cloud information.
  3 in total

Review 1.  Hydrocephalus and mucopolysaccharidoses: what do we know and what do we not know?

Authors:  Amauri Dalla Corte; Carolina F M de Souza; Maurício Anés; Roberto Giugliani
Journal:  Childs Nerv Syst       Date:  2017-06-07       Impact factor: 1.475

2.  The neutralization of heparan sulfate by heparin-binding copolymer as a potential therapeutic target.

Authors:  Bartlomiej Kalaska; Joanna Miklosz; Kamil Kamiński; Bogdan Musielak; Shin-Ichi Yusa; Dariusz Pawlak; Maria Nowakowska; Krzysztof Szczubiałka; Andrzej Mogielnicki
Journal:  RSC Adv       Date:  2019-01-23       Impact factor: 4.036

3.  alpha-L-iduronidase therapy for mucopolysaccharidosis type I.

Authors:  Jakub Tolar; Paul J Orchard
Journal:  Biologics       Date:  2008-12
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.